Listed

Standard Biotools Inc.: Form 10-Q for the period ended Mar 31, 2021

Filed with the SEC on May 7, 2021 and accepted by EDGAR at May 7, 2021, 17:30 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2021-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2021-01-01 to 2021-03-31$32.8mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2021-01-01 to 2021-03-31$10.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2021-01-01 to 2021-03-31$27.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2021-01-01 to 2021-03-31−$19.3mus-gaap:OperatingIncomeLoss
Interest expense3 months2021-01-01 to 2021-03-31$887.0kus-gaap:InterestExpense
Income tax3 months2021-01-01 to 2021-03-31−$1.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2021-01-01 to 2021-03-31−$18.8mus-gaap:NetIncomeLoss
Operating cash flow3 months2021-01-01 to 2021-03-31−$12.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2021-01-01 to 2021-03-31$6.9mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2021-03-31$49.7mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2021-03-31$96.3mus-gaap:AssetsCurrent
Total assetsAt period end2021-03-31$305.2mus-gaap:Assets
Current liabilitiesAt period end2021-03-31$53.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2021-03-31$182.3mus-gaap:Liabilities
Shareholders' equityAt period end2021-03-31$122.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001628280-21-009552. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.